Clinical study of transcutaneous vaccination using a hydrogel patch for tetanus and diphtheria

Vaccine

Volumn 30, Issue 10, 2012, Pages 1847-1854

  Hirobe, Sachiko ^a   Matsuo, Kazuhiko ^a   Quan, Ying Shu ^b   Kamiyama, Fumio ^b   Morito, Hironori ^c   Asada, Hideo ^c   Takaya, Yusuke ^d   Mukai, Yohei ^a   Okada, Naoki ^a   Nakagawa, Shinsaku ^a  

^a OSAKA UNIVERSITY   (Japan)

^b CosMED Pharmaceutical Co Ltd ^*  (Japan)

^c NARA MEDICAL UNIVERSITY   (Japan)

^d Integral Corp   (Japan)

Author keywords

Clinical study; Diphtheria; Hydrogel patch; Tetanus; Transcutaneous immunization

Indexed keywords

ANTIGEN; DIPHTHERIA TOXOID; TETANUS TOXOID; WATER;

ADULT; AGED; ANIMAL EXPERIMENT; ANTIBODY TITER; ARTICLE; BLOOD TESTIS BARRIER; DEVELOPING COUNTRY; DIPHTHERIA; DRUG FORMULATION; DRUG SAFETY; FEMALE; HUMAN; HYDROGEL; IMMUNE SYSTEM; IMMUNIZATION; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAMAN SPECTROMETRY; SKIN IRRITATION; STRATUM CORNEUM; STUDENT T TEST; TETANUS; VACCINATION; VOLUNTEER;

ADULT; AGED; ANIMALS; ANTIBODIES, BACTERIAL; DIPHTHERIA; DIPHTHERIA TOXOID; FEMALE; HUMANS; HYDROGELS; IMMUNOGLOBULIN G; MALE; MICE; MIDDLE AGED; SKIN; TETANUS; TETANUS TOXOID; TRANSDERMAL PATCH; VACCINATION; YOUNG ADULT;

EID: 84857452696     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.12.130     Document Type: Article

References (32)

1. Leppin A., Aro A.R. Risk perceptions related to SARS and avian influenza: theoretical foundations of current empirical research. Int J Behav Med 2009, 16(1):7-29.
2. Haque A., Lucas B., Hober D. Influenza A/H5N1 virus outbreaks and preparedness to avert flu pandemic. Ann Biol Clin (Paris) 2007, 65(2):125-133.
3. Valadas E., Antunes F. Tuberculosis, a re-emergent disease. Eur J Radiol 2005, 55(2):154-157.
4. Campbell C.C. Malaria: an emerging and re-emerging global plague. FEMS Immunol Med Microbiol 1997, 18(4):325-331.
5. Jones J.H., Salathe M. Early assessment of anxiety and behavioral response to novel swine-origin influenza A(H1N1). PLoS One 2009, 4(12):e8032.
6. Azad N., Rojanasakul Y. Vaccine delivery - current trends and future. Curr Drug Deliv 2006, 3(2):137-146.
7. Kersten G., Hirschberg H. Needle-free vaccine delivery. Expert Opin Drug Deliv 2007, 4(5):459-474.
8. Glenn G.M., Scharton-Kersten T., Alving C.R. Advances in vaccine delivery: transcutaneous immunisation. Expert Opin Investig Drugs 1999, 8(6):797-805.
9. Levine M.M. Can needle-free administration of vaccines become the norm in global immunization?. Nat Med 2003, 9(1):99-103.
10. Mathers A.R., Larregina A.T. Professional antigen-presenting cells of the skin. Immunol Res 2006, 36(1-3):127-136.
11. Metz M., Siebenhaar F., Maurer M. Mast cell functions in the innate skin immune system. Immunobiology 2008, 213(3-4):251-260.
12. Sugita K., Kabashima K., Atarashi K., Shimauchi T., Kobayashi M., Tokura Y. Innate immunity mediated by epidermal keratinocytes promotes acquired immunity involving Langerhans cells and T cells in the skin. Clin Exp Immunol 2007, 147(1):176-183.
13. Mutyambizi K., Berger C.L., Edelson R.L. The balance between immunity and tolerance: the role of Langerhans cells. Cell Mol Life Sci 2009, 66(5):831-840.
14. Rougier A., Rallis M., Krien P., Lotte C. In vivo percutaneous absorption: a key role for stratum corneum/vehicle partitioning. Arch Dermatol Res 1990, 282(8):498-505.
15. Bos J.D., Meinardi M.M. The 500 Dalton rule for the skin penetration of chemical compounds and drugs. Exp Dermatol 2000, 9(3):165-169.
16. Barry B.W. Breaching the skin's barrier to drugs. Nat Biotechnol 2004, 22(2):165-167.
17. Zhao Y.L., Murthy S.N., Manjili M.H., Guan L.J., Sen A., Hui S.W. Induction of cytotoxic T-lymphocytes by electroporation-enhanced needle-free skin immunization. Vaccine 2006, 24(9):1282-1290.
18. Laddy D.J., Yan J., Khan A.S., Andersen H., Cohn A., Greenhouse J., et al. Electroporation of synthetic DNA antigens offers protection in nonhuman primates challenged with highly pathogenic avian influenza virus. J Virol 2009, 83(9):4624-4630.
19. Batheja P., Thakur R., Michniak B. Transdermal iontophoresis. Expert Opin Drug Deliv 2006, 3(1):127-138.
20. Wang Y., Thakur R., Fan Q., Michniak B. Transdermal iontophoresis: combination strategies to improve transdermal iontophoretic drug delivery. Eur J Pharm Biopharm 2005, 60(2):179-191.
21. Ishii Y., Nakae T., Sakamoto F., Matsuo K., Quan Y.S., Kamiyama F., et al. A transcutaneous vaccination system using a hydrogel patch for viral and bacterial infection. J Control Release 2008, 131(2):113-120.
22. Matsuo K., Ishii Y., Quan Y.S., Kamiyama F., Mukai Y., Yoshioka Y., et al. Transcutaneous vaccination using a hydrogel patch induces effective immune responses to tetanus and diphtheria toxoid in hairless rat. J Control Release 2011, 149(1):15-20.
23. Matsuo K., Ishii Y., Quan Y.S., Kamiyama F., Mukai Y., Okada N., et al. Characterization of transcutaneous protein delivery by a hydrogel patch in animal, human, and tissue-engineered skin models. Biol Pharm Bull 2011, 34(4):586-589.
24. Fregert S. Manual of contact dermatitis 1981, Munksgaard, Copenhagen, pp. 71-76.
25. Ivens U., Serup J., O'Goshi K. Allergy patch test reading from photographic images: disagreement on ICDRG grading but agreement on simplified tripartite reading. Skin Res Technol 2007, 13(1):110-113.
26. Caspers P.J., Lucassen G.W., Carter E.A., Bruining H.A., Puppels G.J. In vivo confocal Raman microspectroscopy of the skin: noninvasive determination of molecular concentration profiles. J Invest Dermatol 2001, 116(3):434-442.
27. De Paepe K., Wibaux A., Ward C., Rogiers V. Skin efficacy and biophysical assessment of glycerol-containing hydrocolloid patches. Skin Pharmacol Physiol 2009, 22(5):258-265.
28. Hood H.L., Kraeling M.E., Robl M.G., Bronaugh R.L. The effects of an alpha hydroxy acid (glycolic acid) on hairless guinea pig skin permeability. Food Chem Toxicol 1999, 37(11):1105-1111.
29. Etchart N., Hennino A., Friede M., Dahel K., Dupouy M., Goujon-Henry C., et al. Safety and efficacy of transcutaneous vaccination using a patch with the live-attenuated measles vaccine in humans. Vaccine 2007, 25(39-40):6891-6899.
30. Glenn G.M., Taylor D.N., Li X., Frankel S., Montemarano A., Alving C.R. Transcutaneous immunization: a human vaccine delivery strategy using a patch. Nat Med 2000, 6(12):1403-1406.
31. World Health Organization. The immunological basis for immunization series, Module 3 Tetanus; 2007.
32. World Health Organization. The immunological basis for immunization series, Module 2 Diphtheria; 2009.